CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Summit Therapeutics Q3 2026 net loss narrows 10% year over year to $208.4 million

By Public Technologies
  • Summit Therapeutics’ third-quarter 2026 net loss narrowed 10% year over year to $208.4 million.
  • Research and development expenses rose 29% year over year to $169.1 million, driven by expanded ivonescimab studies and development costs.
  • Cash and investments totaled $629.8 million at September 30; AstraZeneca completed a $2 billion strategic equity investment on October 5.
  • The FDA’s decision on ivonescimab with chemotherapy for previously treated EGFR-mutated advanced lung cancer is targeted for November 14, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Summit Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611041636BIZWIRE_USPR_____20261104_BW735455) on November 04, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk